The given chart illustrates the distribution of the total sales of a particular drug company on three continents between 2002 and 2006.
Overall, Asia was the only area witnessing a continuous increase throughout the period, thus, claiming the majority of sales in the chart in 2006. This is in stark contrast to Europe and America, where sales percentages fluctuated during the timeframe.
During the period from 2002 to 2004, America was the largest market for the company, accounting for 41% of total sales. Nevertheless, It was witnessed that in 2004, America’s sales percentages hit the bottom at 27%, which gradually increased until finishing at 30% in 2006.
On the other hand, the sales figures of the drug company in Asia and Europe saw a gradual increase to 35% and 38%, respectively in 2004. However, there were significant changes in 2006, while Asia became the most successful market for the company with 40% of total sales, exceeding both Europe and America, Europe’s sales showed a downward trend to 30%.
